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Oxidized regenerated cellulose (Ethicon Surgicel) is often used during surgery to achieve
hemostasis. The appearance of Surgicel on postoperative computed tomography (CT) may
be mistaken for abscess. Meanwhile, the literature regarding its ultrasound appearance
remains scant. We report the CT and sonographic appearances of Surgicel in the right
ovary of a 21-year-old woman presenting to the emergency department with pelvic pain 7
days after ovarian cystectomy. The patient was discharged home with only supportive
measures, and follow-up ultrasound obtained 26 days later demonstrated resolution of the
sonographic abnormality. This case stresses the importance of familiarity with common
imaging appearances of topical hemostatic agents and the need to correlate radiologic
findings with the patient's clinical condition and prior operative reports to identify patients
suitable for conservative management.
Copyright © 2015, the Authors. Published by Elsevier Inc. under copyright license from the
University of Washington. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Surgicel (Ethicon, Inc, a Johnson & Johnson company) is a
resorbable agent composed of oxidized cellulose polymer used
to achieve hemostasis during surgical procedures. Biodegrada-
tionof Surgicel beginswithin24-48hours and is completed inas
early as 1-2 weeks [1]. Perhaps for this reason, there is a paucity
of literature regarding its radiologic appearance, particularly on
ultrasound, as computed tomography (CT) isoften thepreferred
imaging modality in the immediate postoperative period.lared that no competing
hang).
blished by Elsevier Inc. u
ND license (http://creativWe present the CT and ultrasound appearance of Surgicel
used during ovarian cystectomy of a 21-year-old patient pre-
senting with postoperative pelvic pain.Case report
A 21-year-oldwomanpresented to the emergency department
with suprapubic and pelvic pain. At presentation, the patient
was afebrile with a normal white blood cell count and benigninterests exist.
nder copyright license from the University of Washington. This is
ecommons.org/licenses/by-nc-nd/4.0/).
Fig. 2 e Initial pelvic ultrasound obtained within 3 hours of
the computed tomography shows an echogenic mass in
the right ovary with “dirty” posterior acoustic shadowing
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had undergone laparoscopy and right ovarian cystectomy for
a large symptomatic ovarian cyst. A CT scan of the abdomen
and pelvis performed in the emergency department with oral
and intravenous contrast revealed a small collection in the
right adnexal surgical bed containing minute foci of gas
(Fig. 1). A pelvic ultrasound was performed on the same night,
demonstrating a 3.3 1.3 1.6 cm echogenicmass in the right
ovary associated with “dirty” posterior acoustic shadowing
(Fig. 2). There was no blood flow within the mass on color
Doppler ultrasound although blood flow to the remainder of
the right ovary was preserved. The uterus and left ovary
appeared normal, and there was no pelvic free fluid.
The initial differential diagnosis included postsurgical
changes, ovarian torsion, or gas-containing postoperative
abscess. A detailed review of the operative report revealed
that a small piece of Surgicel had been placed over the cyst
wall surface of the right ovary during her cystectomy. Both the
CT and pelvic ultrasound findings were felt to be attributable
to the postoperative appearance of Surgicel. The patient was
managed conservatively and discharged home from the
emergency department. Follow-up pelvic ultrasound per-
formed 33 days after her initial surgery demonstrated reso-
lution of the echogenic mass within the right ovary (Fig. 3).
(annotated by the white arrow).Discussion
Given the importance of control of bleeding during surgery,
use of topical hemostatic agents has become widespread and
continues to evolve. Surgicel is a hemostatic agent commonly
used in gynecologic and pelvic surgery. It is readily available
and relatively inexpensive. It can easily be brought into the
peritoneal cavity via laparoscopy trocars, making itFig. 1 e Initial computed tomography of abdomen/pelvis
demonstrates a small right adnexal collection containing
minute foci of gas (annotated by the white arrow).compatible with minimally invasive surgery. It is then placed
directly onto the tissue where assurance of hemostasis is
desired. Surgicel is believed to achieve hemostasis through
multiple mechanisms including activation of the intrinsic
coagulation pathway, creation of a low pH environment to
promote vasoconstriction, and formation of a scaffold for the
establishment of a platelet plug [1,2]. Despite their widespread
use, the imaging appearances of topical hemostatic agentsFig. 3 e Follow-up pelvic ultrasound performed 33 days
after the initial surgery shows complete resolution of the
echogenic mass within the right ovary.
R a d i o l o g y C a s e R e p o r t s 1 0 ( 2 0 1 5 ) 3 9e4 1 41remain underreported in radiologic literature, perhaps owing
to their limited durability (and therefore limited imaging), the
diversity of hemostatic formulations, and the breadth of sur-
geries and anatomic locations in which they are used [3].
On postoperative CT scan, Surgicel (oxidized regenerated
cellulose) has been described as a heterogeneous mass or
collection containing small locules of gas, potentially leading
to themisdiagnosis of abscess and subsequent futile attempts
at drainage [4,5]. There have been few reports on the imaging
appearance of Surgicel on ultrasound. In our case, the sono-
graphic appearance of Surgicel as a highly echogenic mass
demonstrating posterior shadowing and reverberation is
consistent with prior descriptions and is felt to be secondary
to small trapped air bubbles [6]. Although Surgicel can be
quickly resorbed, it may persist for 4-8 weeks in the body and
even years after the initial surgery [7].
The reported case is unique given the location of Surgicel in
the ovary and the inclusion of sonographic findings. A previ-
ous report of a foreign-body granulomatous reaction to Sur-
gicel mimicking an ovarian mass described only histologic
findings [8]. Behbehani and Tulandi [5] reported the CT
appearance of intrapelvic Surgicel after gynecological surgery,
but none of the cases had ultrasound correlates or involved
the intraovarian placement of Surgicel. The combination of CT
and ultrasound imaging findings in this patient was consis-
tent with the history of Surgicel utilization during pelvic sur-
gery. An abscess was felt to be unlikely given the lack of
concerning clinical and laboratory findings. Ovarian torsion,
although initially a diagnostic consideration, was excluded
based on the lack of associated imaging features such as
abnormal ovarian location, asymmetric enlargement of the
ovary, peripheralization of the follicles, or absence of vascular
flow on color Doppler ultrasound [9]. Familiarity with the pa-
tient's surgical history prevented additional costs and risks to
the patient associated with unnecessary work-up and
procedures.In conclusion, knowledge of the utilization and imaging
appearance of Surgicel is important for the radiologist inter-
preting ultrasound and CT imaging performed after pelvic
surgery to prevent erroneous diagnosis of abscess and avoid
unnecessary interventions.r e f e r e n c e s
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